Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
Express Scripts
Harvard Business School
Merck
Medtronic

Last Updated: June 24, 2022

MOMETASONE FUROATE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

What are the generic drug sources for mometasone furoate and what is the scope of patent protection?

Mometasone furoate is the generic ingredient in eight branded drugs marketed by Organon, Merck Sharp Dohme, Anda Repository, Cosette, Fougera Pharms, Glenmark Generics, Taro, Intersect Ent Inc, Padagis Israel, Padagis Us, Torrent, Amneal Pharms, Apotex Inc, Perrigo Pharma Intl, and Glenmark Specialty, and is included in twenty-nine NDAs. There are twenty-five patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Mometasone furoate has forty-seven patent family members in twelve countries.

There are twenty-seven drug master file entries for mometasone furoate. Eighteen suppliers are listed for this compound.

Drug Prices for MOMETASONE FUROATE

See drug prices for MOMETASONE FUROATE

Drug Sales Revenue Trends for MOMETASONE FUROATE

See drug sales revenues for MOMETASONE FUROATE

Recent Clinical Trials for MOMETASONE FUROATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Pi Research Consultancy Center, BangladeshEarly Phase 1
Hvidovre University HospitalPhase 4
Xijing HospitalN/A

See all MOMETASONE FUROATE clinical trials

Medical Subject Heading (MeSH) Categories for MOMETASONE FUROATE
Paragraph IV (Patent) Challenges for MOMETASONE FUROATE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
NASONEX Nasal Spray mometasone furoate 50 mcg/ Spray 020762 1 2009-08-07
ELOCON Topical Solution (Lotion) mometasone furoate 0.1% 019796 1 2004-06-10

US Patents and Regulatory Information for MOMETASONE FUROATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Anda Repository MOMETASONE FUROATE mometasone furoate CREAM;TOPICAL 076591-001 Apr 18, 2007 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Taro MOMETASONE FUROATE mometasone furoate CREAM;TOPICAL 076679-001 Dec 21, 2004 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Fougera Pharms MOMETASONE FUROATE mometasone furoate LOTION;TOPICAL 075919-001 Nov 29, 2007 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Intersect Ent Inc SINUVA mometasone furoate IMPLANT;IMPLANTATION 209310-001 Dec 8, 2017 RX Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Intersect Ent Inc SINUVA mometasone furoate IMPLANT;IMPLANTATION 209310-001 Dec 8, 2017 RX Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for MOMETASONE FUROATE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon ASMANEX HFA mometasone furoate AEROSOL, METERED;INHALATION 205641-001 Apr 25, 2014 See Plans and Pricing See Plans and Pricing
Organon ASMANEX TWISTHALER mometasone furoate POWDER;INHALATION 021067-002 Feb 1, 2008 See Plans and Pricing See Plans and Pricing
Organon ASMANEX TWISTHALER mometasone furoate POWDER;INHALATION 021067-002 Feb 1, 2008 See Plans and Pricing See Plans and Pricing
Organon ASMANEX TWISTHALER mometasone furoate POWDER;INHALATION 021067-002 Feb 1, 2008 See Plans and Pricing See Plans and Pricing
Organon ASMANEX TWISTHALER mometasone furoate POWDER;INHALATION 021067-002 Feb 1, 2008 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for MOMETASONE FUROATE

Country Patent Number Title Estimated Expiration
China 106039547 可展开装置及其使用方法 (Expandable devices and methods therefor) See Plans and Pricing
Japan 6757761 See Plans and Pricing
Japan 2016512129 副鼻腔状態を処置するためのシステム、デバイスおよび方法 See Plans and Pricing
Canada 2761769 DISPOSITIFS EXPANSIBLES ET PROCEDES POUR LES UTILISER (EXPANDABLE DEVICES AND METHODS THEREFOR) See Plans and Pricing
World Intellectual Property Organization (WIPO) 2010132648 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for MOMETASONE FUROATE

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0548114 SPC/GB97/064 United Kingdom See Plans and Pricing PRODUCT NAME: MOMETASONE FUROATE MONOHYDRATE; REGISTERED: FR AMM 343012.6 19970219; UK 00201/0216 19970410
0112669 96C0002 Belgium See Plans and Pricing PRODUCT NAME: MOMETASONE FUROATE; NAT. REGISTRATION NO/DATE: NL 19601 19950919; FIRST REGISTRATION: GR - 10681/89 19900622
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
Mallinckrodt
Baxter
Colorcon
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.